{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:00:46Z","timestamp":1788505246369,"version":"build-2803163510"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1637,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1111\/j.1600-0897.2011.00988.x","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T17:45:09Z","timestamp":1299692709000},"page":"230-236","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Significance of Soluble Fas and Soluble Fas Ligand in Serum of Patients with Complete Hydatidiform Moles"],"prefix":"10.1111","volume":"66","author":[{"given":"Simmi","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Deval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Salhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,9]]},"reference":[{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB1|cit1","volume-title":"Pathology of the Human Placenta","author":"Benirschke","year":"2001"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cncr.20767","article-title":"Mcl-1 expression in GTD correlated with clinical outcome","volume":"103","author":"Fong","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10495-005-1018-9","article-title":"Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors","volume":"10","author":"Kondera-Anasz","year":"2005","journal-title":"Apoptosis"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/01.shk.0000097248.97298.ea","article-title":"Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humans","volume":"20","author":"Marsik","year":"2003","journal-title":"Shock"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"e4728","DOI":"10.1371\/journal.pone.0004728","article-title":"The role of MMP7 and its cross-talk with the FAS\/FASL system during the acquisition of chemoresistance to oxaliplatin","volume":"4","author":"Almendro","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB6|cit6","first-page":"1108","article-title":"Soluble Fas and cancer","volume":"7","author":"Owen-Schaub","year":"2001","journal-title":"Clin Can Res"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-5347(01)62960-4","article-title":"Prognostic significance of soluble Fas in the serum of patients with bladder cancer","volume":"160","author":"Mizutani","year":"1998","journal-title":"J Urol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2249.1998.00569.x","article-title":"Elevated serum levels of soluble Fas-APO-1 (CD95) in patients with hepatocellular carcinoma","volume":"112","author":"Jodo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB9|cit9","first-page":"3529","article-title":"Circulating soluble Fas concentration in breast cancer patients","volume":"5","author":"Ueno","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0090-4295(99)00379-9","article-title":"Soluble Fas in serum from patients with renal cell carcinoma","volume":"55","author":"Nonomura","year":"2000","journal-title":"Urology"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB11|cit11","first-page":"3576","article-title":"Serum soluble Fas level as a prognostic factor in patients with gynecological malignancies","volume":"6","author":"Konno","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0029-7844(00)00840-1","article-title":"Serum soluble Fas levels in ovarian cancer","volume":"96","author":"Hefler","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1634\/stemcells.22-6-908","article-title":"Fas ligand as a tool for immunosuppression and generation of immune tolerance","volume":"22","author":"Bohana-Kashtan","year":"2004","journal-title":"Stem Cells"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2249.2008.03630.x","article-title":"Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis","volume":"152","author":"Sellner","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/ar2181","article-title":"Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis","volume":"9","author":"Kim","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.8755-8920.2000.430402.x","article-title":"Fas antigen expression on the decidual lymphocytes of pre-eclamptic patients","volume":"43","author":"Darmochwal-Kolarz","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.8755-8920.2000.440605.x","article-title":"Enhanced expression of Fas-associated proteins in decidual and trophoblastic tissues in pregnancy-induced hypertension","volume":"44","author":"Koenig","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1600-0897.2002.01119.x","article-title":"Expression of functional Fas ligand in choriocarcinoma","volume":"48","author":"Hammer","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0897.2008.00583.x","article-title":"Placental fas\/fas ligand expression in early pregnancy losses","volume":"60","author":"Guvendag Guven","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.cdd.4401185","article-title":"Protein-based therapeutic approaches targeting death receptors","volume":"10","author":"French","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.cdd.4401016","article-title":"Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells","volume":"9","author":"Matsuki","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0897.1998.tb00396.x","article-title":"Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease","volume":"40","author":"Mor","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1095\/biolreprod64.3.784","article-title":"Expression of Fas\/Fas ligand by decidual leukocytes in hydatidiform mole","volume":"64","author":"Wongweragiat","year":"2001","journal-title":"Biol Reprod"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.placenta.2003.08.020","article-title":"Placental Fas and FasL expression in normal early, term and molar pregnancy","volume":"25","author":"Pongcharoen","year":"2004","journal-title":"Placenta"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB25|cit25","first-page":"132","article-title":"Serum levels of sFas and sFasL during chemotherapy of lung cancer","volume":"29","author":"Naumnik","year":"2007","journal-title":"Exp Oncol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB26|cit26","article-title":"Fas-FasL system in molar pregnancy","author":"Soni","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3748\/wjg.v9.i12.2671","article-title":"Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas\/FasL system","volume":"9","author":"Wang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/JPM.2005.085","article-title":"The role of Fas mediated apoptosis in preeclampsia","volume":"33","author":"Neale","year":"2005","journal-title":"J Perinat Med"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB29|cit29","first-page":"199","article-title":"Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus","volume":"45","author":"Kozlowski","year":"2007","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/eje.1.01997","article-title":"Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG \u03b1- and \u03b2-subunits, and their ratios","volume":"153","author":"Trommel","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1600-0897.2011.00988.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4049\/jimmunol.171.5.2305","article-title":"Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas-Fas ligand system","volume":"171","author":"Kayisli","year":"2003","journal-title":"J Immunol"}],"container-title":["American Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0897.2011.00988.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0897.2011.00988.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T17:39:52Z","timestamp":1625679592000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0897.2011.00988.x"}},"subtitle":["SFAS AND SFASL IN COMPLETE HYDATIDIFORM MOLES"],"short-title":[],"issued":{"date-parts":[[2011,3,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0897.2011.00988.x","relation":{},"ISSN":["1046-7408"],"issn-type":[{"value":"1046-7408","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,9]]}}}